Cargando…

Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease

BACKGROUND: Exosomes play an important role in metabolic-associated fatty liver disease (MAFLD), but the mechanism by which exosomes participate in MAFLD still remain unclear. AIM: To figure out the function of lipotoxic exosomal miR-1297 in MAFLD. METHODS: MicroRNA sequencing was used to detect dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xin, Luo, Sheng-Zheng, Xu, Zi-Xin, Zhou, Cui, Li, Zheng-Hong, Zhou, Xiao-Yan, Xu, Ming-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047533/
https://www.ncbi.nlm.nih.gov/pubmed/33911465
http://dx.doi.org/10.3748/wjg.v27.i14.1419
_version_ 1783679059792756736
author Luo, Xin
Luo, Sheng-Zheng
Xu, Zi-Xin
Zhou, Cui
Li, Zheng-Hong
Zhou, Xiao-Yan
Xu, Ming-Yi
author_facet Luo, Xin
Luo, Sheng-Zheng
Xu, Zi-Xin
Zhou, Cui
Li, Zheng-Hong
Zhou, Xiao-Yan
Xu, Ming-Yi
author_sort Luo, Xin
collection PubMed
description BACKGROUND: Exosomes play an important role in metabolic-associated fatty liver disease (MAFLD), but the mechanism by which exosomes participate in MAFLD still remain unclear. AIM: To figure out the function of lipotoxic exosomal miR-1297 in MAFLD. METHODS: MicroRNA sequencing was used to detect differentially expressed miRNAs (DE-miR) in lipotoxic exosomes derived from primary hepatocytes. Bioinformatic tools were applied to analyze the target genes and pathways regulated by the DE-miRs. Quantitative real-time PCR (qPCR) was conducted for the verification of DE-miRs. qPCR, western blot, immunofluorescence staining and ethynyl-20-deoxyuridine assay were used to evaluate the function of lipotoxic exosomal miR-1297 on hepatic stellate cells (LX2 cells). A luciferase reporter experiment was performed to confirm the relationship of miR-1297 and its target gene PTEN. RESULTS: MicroRNA sequencing revealed that there were 61 exosomal DE-miRs (P < 0.05) with a fold-change > 2 from palmitic acid treated primary hepatocytes compared with the vehicle control group. miR-1297 was the most highly upregulated according to the microRNA sequencing. Bioinformatic tools showed a variety of target genes and pathways regulated by these DE-miRs were related to liver fibrosis. miR-1297 was overexpressed in exosomes derived from lipotoxic hepatocytes by qPCR. Fibrosis promoting genes (α-SMA, PCNA) were altered in LX2 cells after miR-1297 overexpression or miR-1297-rich lipotoxic exosome incubation via qPCR and western blot analysis. Immunofluorescence staining and ethynyl-20-deoxyuridine staining demonstrated that the activation and proliferation of LX2 cells were also promoted after the above treatment. PTEN was found to be the target gene of miR-1297 and knocking down PTEN contributed to the activation and proliferation of LX2 cells via modulating the PI3K/AKT signaling pathway. CONCLUSION: miR-1297 was overexpressed in exosomes derived from lipotoxic hepatocytes. The lipotoxic hepatocyte-derived exosomal miR-1297 could promote the activation and proliferation of hepatic stellate cells through the PTEN/PI3K/AKT signaling pathway, accelerating the progression of MAFLD.
format Online
Article
Text
id pubmed-8047533
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-80475332021-04-27 Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease Luo, Xin Luo, Sheng-Zheng Xu, Zi-Xin Zhou, Cui Li, Zheng-Hong Zhou, Xiao-Yan Xu, Ming-Yi World J Gastroenterol Basic Study BACKGROUND: Exosomes play an important role in metabolic-associated fatty liver disease (MAFLD), but the mechanism by which exosomes participate in MAFLD still remain unclear. AIM: To figure out the function of lipotoxic exosomal miR-1297 in MAFLD. METHODS: MicroRNA sequencing was used to detect differentially expressed miRNAs (DE-miR) in lipotoxic exosomes derived from primary hepatocytes. Bioinformatic tools were applied to analyze the target genes and pathways regulated by the DE-miRs. Quantitative real-time PCR (qPCR) was conducted for the verification of DE-miRs. qPCR, western blot, immunofluorescence staining and ethynyl-20-deoxyuridine assay were used to evaluate the function of lipotoxic exosomal miR-1297 on hepatic stellate cells (LX2 cells). A luciferase reporter experiment was performed to confirm the relationship of miR-1297 and its target gene PTEN. RESULTS: MicroRNA sequencing revealed that there were 61 exosomal DE-miRs (P < 0.05) with a fold-change > 2 from palmitic acid treated primary hepatocytes compared with the vehicle control group. miR-1297 was the most highly upregulated according to the microRNA sequencing. Bioinformatic tools showed a variety of target genes and pathways regulated by these DE-miRs were related to liver fibrosis. miR-1297 was overexpressed in exosomes derived from lipotoxic hepatocytes by qPCR. Fibrosis promoting genes (α-SMA, PCNA) were altered in LX2 cells after miR-1297 overexpression or miR-1297-rich lipotoxic exosome incubation via qPCR and western blot analysis. Immunofluorescence staining and ethynyl-20-deoxyuridine staining demonstrated that the activation and proliferation of LX2 cells were also promoted after the above treatment. PTEN was found to be the target gene of miR-1297 and knocking down PTEN contributed to the activation and proliferation of LX2 cells via modulating the PI3K/AKT signaling pathway. CONCLUSION: miR-1297 was overexpressed in exosomes derived from lipotoxic hepatocytes. The lipotoxic hepatocyte-derived exosomal miR-1297 could promote the activation and proliferation of hepatic stellate cells through the PTEN/PI3K/AKT signaling pathway, accelerating the progression of MAFLD. Baishideng Publishing Group Inc 2021-04-14 2021-04-14 /pmc/articles/PMC8047533/ /pubmed/33911465 http://dx.doi.org/10.3748/wjg.v27.i14.1419 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Basic Study
Luo, Xin
Luo, Sheng-Zheng
Xu, Zi-Xin
Zhou, Cui
Li, Zheng-Hong
Zhou, Xiao-Yan
Xu, Ming-Yi
Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease
title Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease
title_full Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease
title_fullStr Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease
title_full_unstemmed Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease
title_short Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease
title_sort lipotoxic hepatocyte-derived exosomal mir-1297 promotes hepatic stellate cell activation through the pten signaling pathway in metabolic-associated fatty liver disease
topic Basic Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047533/
https://www.ncbi.nlm.nih.gov/pubmed/33911465
http://dx.doi.org/10.3748/wjg.v27.i14.1419
work_keys_str_mv AT luoxin lipotoxichepatocytederivedexosomalmir1297promoteshepaticstellatecellactivationthroughtheptensignalingpathwayinmetabolicassociatedfattyliverdisease
AT luoshengzheng lipotoxichepatocytederivedexosomalmir1297promoteshepaticstellatecellactivationthroughtheptensignalingpathwayinmetabolicassociatedfattyliverdisease
AT xuzixin lipotoxichepatocytederivedexosomalmir1297promoteshepaticstellatecellactivationthroughtheptensignalingpathwayinmetabolicassociatedfattyliverdisease
AT zhoucui lipotoxichepatocytederivedexosomalmir1297promoteshepaticstellatecellactivationthroughtheptensignalingpathwayinmetabolicassociatedfattyliverdisease
AT lizhenghong lipotoxichepatocytederivedexosomalmir1297promoteshepaticstellatecellactivationthroughtheptensignalingpathwayinmetabolicassociatedfattyliverdisease
AT zhouxiaoyan lipotoxichepatocytederivedexosomalmir1297promoteshepaticstellatecellactivationthroughtheptensignalingpathwayinmetabolicassociatedfattyliverdisease
AT xumingyi lipotoxichepatocytederivedexosomalmir1297promoteshepaticstellatecellactivationthroughtheptensignalingpathwayinmetabolicassociatedfattyliverdisease